Our Team
Our core principle is to invest in people, communities, and the success of our clients.
Meet Our Team of Experts
Our management team is a young group of passionate entrepreneurs who bring a fresh perspective and innovative ideas to the table. With extensive knowledge and expertise honed through experiences at leading international organizations, they are committed to driving success through strategic vision and collaborative efforts.
Sreekanth Gonugunta
Founder & CEO, Mayan Farma
Sreekanth Gonugunta is an accomplished leader with over 15 years of experience in the pharmaceutical marketing and sales industry, both in India and International Markets....
Sreekanth Gonugunta
Founder & CEO, Mayan Farma
With a proven track record of expanding market share and creating value, Sreekanth excels in implementing strategic sales initiatives and targeted market development. His career is highlighted with his association with some of the world’s leading pharmaceutical companies, including Dr. Reddy's Laboratories, Hetero, Seven Pharma, and Aculife Health, showcasing his ability to navigate and thrive in competitive markets.
Sreekanth has been instrumental in launching numerous successful products in the Latin American market, building strong relationships with key stakeholders across both B2C and B2B sectors. His deep understanding of the region's pharmaceutical landscape has made him a trusted expert in developing tailored solutions for complex market dynamics.
Beyond his strategic leadership, Sreekanth brings expertise in Customer Relationship Management (CRM), innovative product promotion strategies, and the efficient management of critical territory data. His multifaceted skill set and commitment to excellence continue to position Mayan Farma as a trusted partner in the Latin American pharmaceutical industry.
Surya Srimanthula
Co-Founder & Director, Mayan Farma
Surya Srimanthula is a passionate pharmaceutical professional with over 12 years of expertise in sales, brand management, and strategic marketing....
Surya Srimanthula
Co-Founder & Director, Mayan Farma
Before embarking on his entrepreneurial journey with Mayan Farma, Surya gained valuable experience working with esteemed organizations such as Pfizer, Hetero Drugs, and Levo Pharma. In these roles, he consistently showcased his ability to design and implement innovative marketing frameworks that fuelled significant business growth and market expansion.
In addition to his leadership at Mayan Farma, Surya extends his expertise to Drug Genie, A UAE based Research & development Company, where he serves as board member and Director. His dedication in driving business excellence remains a hallmark of his professional Journey.
Saravanan Veerasamy
Director & Partner
Saravanan is a seasoned expert with nearly two decades of experience in navigating the intricate world of international pharmaceutical regulations....
Saravanan Veerasamy
Director & Partner
As a Director at Mayan Farma, his team brings unparalleled knowledge of global regulatory frameworks, driving the company’s strategic initiatives and ensuring strict compliance with all regulatory requirements. A founding member of Mayan Farma, Saravanan has played a pivotal role in establishing a strong foundation for the company’s operations. His impressive career includes significant contributions to renowned pharmaceutical organizations such as Medreich, Biocon, Fresenius Kabi, Aspen Pharma, Julphar, Hetero Drugs, and Amarox. His expertise spans diverse markets, including Brazil, Mexico, and the UAE, reflecting his deep understanding of global pharmaceutical dynamics.
In addition to his leadership at Mayan Farma, Saravanan is also a Director at Gee Group of Companies and Drug Genie, where he continues to nurture innovation and excellence in the pharmaceutical sector. His commitment to regulatory precision and strategic growth underscores his invaluable role in shaping the success of every venture he undertakes.
The Mayan Farma Journey
In this era of innovation, partnering in drug development and building a robust therapeutic pipeline has increasingly been recognized as an important strategy.
Since 2021
IncorporationFounded in Mexico City in December 2021, Mayan Farma began its journey to enhance healthcare access for all.
2022
5 Clients, 15 Dossier SubmissionsIn our first year, we secured agreements with AET, Gland, Optimum, BDR, and Extrovits, submitting over 15 dossiers to COFEPRIS to build a diverse treatment portfolio for underserved patients.
2023
5 New Clients, 35 Dossier SubmissionsThrough a national tender, we secured products valued at 14 million. We also signed agreements with Becton, Natco, Swiss, and Cadila Pharma, submitting 35 dossiers to COFEPRIS, bringing essential treatments closer to those in need.
2023
2 New Market ExpansionsOur reach expanded into South America, specifically Colombia and Chile, reinforcing our commitment to last-mile healthcare.
2024
15+ Happy Clients, 95+ Product PortfolioWith over 95 products in various therapeutic areas, our portfolio now meets the broad healthcare needs of our clients and the patients they serve.